期刊文献+

胰腺癌组织中P21ras、TGF-α及EGFR蛋白的表达 被引量:2

Expressions of P21ras,TGF-α and EGFR proteins in pancreatic carcinoma tissue
暂未订购
导出
摘要 目的:检测原发性胰腺导管腺癌组织中P21ras、转化生长因子-α(TGF-α)及表皮生长因子受体(EGFR)蛋白的表达情况。方法:应用免疫组织化学SP法检测30例原发性胰腺导管腺癌和10例正常胰腺组织中P21ras、TGF-α及EGFR蛋白的表达情况。结果:原发性胰腺导管腺癌组织中P21ras、TGF-α及EGFR的阳性表达率分别为63.3%(19/30)、80.0%(24/30)和70.0%(21/30),均高于正常胰腺组织的1/10、2/10和0(P分别为0.008、0.001和<0.001);P21ras的表达与胰腺癌的病理分级(P=0.042)、临床分期(P=0.007)及淋巴结转移(P=0.023)关系密切,而TGF-α及EGFR的表达与上述指标无明显相关性(P>0.05);胰腺癌组织中TGF-α与EGFR的表达密切关联(rP=0.607,P<0.001)。结论:胰腺癌组织中P21ras蛋白表达是一早期而普遍的事件,检测P21ras蛋白有助于胰腺癌的早期诊断;TGF-α与EGFR能够形成自分泌环,参与胰腺癌的发生。 Aim:To investigate the expressions of P21ras,TGF-α and EGFR proteins in pancreatic carcinoma(PC) tissue.Methods:A total of 30 primary pancreatic ductal adenocarcinoma samples and 10 normal pancreatic tissue samples were collected to detect the expressions of P21ras,TGF-α and EGFR proteins by immunohistochemistry method.Results:The positive rates of P21ras,TGF-α and EGFR in PC tissue were 63.3%(19/30),80.0%(24/30) and 70.0%(21/30),respectively,higher than those of 1/10,2/10,and 0 in normal pancreatic tissue samples(P was 0.008,0.001,and 0.001).The expression of P21ras,but not TGF-α or EGFR,was related with histological grade(P=0.042),clinical stage(P=0.007) and lymph node metastasis(P=0.023) of PC tissue.Positive association was observed between the expressions of TGF-α and EGFR in PC tissue(rP=0.607,P0.001).Conclusion:Increased expression of P21ras is an early molecular event in the pathogenesis of PC,and its detection may be useful for early diagnosis. The autocrine loop of TGF-α/EGFR may contribute to the carcinogenesis of PC.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2010年第3期457-460,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 胰腺癌 P21RAS 转化生长因子-Α 表皮生长因子受体 pancreatic carcinoma P21ras TGF-α EGFR
  • 相关文献

参考文献14

二级参考文献90

  • 1苏震东,骆明德.K-ras基因突变在胰腺癌中的作用研究进展[J].国外医学(消化系疾病分册),2005,25(1):48-51. 被引量:4
  • 2高毅,张晓华,华积德,谢毅,王启松.人胃癌组织DNA聚合酶αmRNA的高表达[J].第一军医大学学报,1994,14(3):182-184. 被引量:6
  • 3曾水林,陆澄,杨鹏,朱建宝,李涛,刘培党,张郢华.胰头后面神经分布的应用解剖学研究[J].东南大学学报(医学版),2006,25(1):20-23. 被引量:2
  • 4杨竹林,李永国,钟德,庄赞根.胰腺癌组织中ER、PR、EGFR表达及相互关系[J].中华消化杂志,1996,16(2):94-96. 被引量:6
  • 5Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer:a randomized controlled trial[ J ]. JAMA ,2007,297 (3) :267 - 277.
  • 6Picozzi VJ, Kozarek RA, Traverso LW. Interferon- based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma [ J ]. Am J Surg,2003,185 ( 5 ) :476 - 480.
  • 7Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection [ J ]. Arch Surg, 1985,120 ( 8 ) :899 - 903.
  • 8Klinkenbijl JH, Jeekel J,Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region:phase Ⅲ trial of the EORTC gastrointestinal tract cancer cooperative group [ J ]. Ann Surg, 1999,230 (6) :776 -782.
  • 9John P. Neoptolemos, Deborah D. Stocken, Helmut Friess. A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer[ J]. N Engl J Med,2004,350 (12) : 1200 - 1201.
  • 10Moore M J, GoldStein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer:a phase m trial of the National Cancer Institute of Canada Clinical Trials Group[J].J Clin Oncol,2007,25 ( 15 ) : 1960 - 1966.

共引文献19

同被引文献15

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部